Specific EGFR mutations predict treatment outcome of stage IIIB/IV patients with chemonaive NSCLC patients receiving first-line gefitinib monotherapy
Resource
J Clin Oncol,26,2745-2753.
Journal
J Clin Oncol
Journal Issue
26
Pages
2745-2753
Date Issued
2008-01
Date
2008-01
Author(s)
Yang, Chih-Hsin
Yu, Chong-Jen
Shih, Jin-Yuan
Chang, Yeun-Chung
Hu, Fu-Chang
Tsai, Meng-Chin
Chen, Kuan-Yu
Lin, Zhong-Zhe
Huang, Ching-Ju
Shun, Chia-Tung
Huang, Chin-Lun
Bean, James
Cheng, Ann-Lii
Pao, William
Yang, Pan-Chyr